Comparison of thrombotic risk between 85 homozygotes and 481 heterozygotes carriers of the factor V Leiden mutation: retrospective analysis from the Procare Study

This publication has 22 references indexed in Scilit:

• Risk of thrombosis in patients homozygous for factor V Leiden [letter; comment]
  Blood, 1995
• A rapid screening method for the factor V Arg506???Gln mutation
  Blood Coagulation & Fibrinolysis, 1995
• Criteria for the Diagnosis of Lupus Anticoagulants: An Update
  Thrombosis and Haemostasis, 1995
• Variability of Thrombosis among Homozygous Siblings with Resistance to Activated Protein C Due to an Arg-to-Gln Mutation in the Gene for Factor V
  New England Journal of Medicine, 1994
• Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.
  Journal of Clinical Investigation, 1994
• Mutation in blood coagulation factor V associated with resistance to activated protein C
  Nature, 1994
• Frequency of a defective response to activated protein C in patients with a history of venous thrombosis [letter; comment]
  Blood, 1994
• Resistance to Activated Protein C as a Basis for Venous Thrombosis
  New England Journal of Medicine, 1994
• Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study
  The Lancet, 1993
• Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.
  Proceedings of the National Academy of Sciences, 1993